Pett Ryan G, Nye Shane
J Am Pharm Assoc (2003). 2016 May-Jun;56(3):237-41. doi: 10.1016/j.japh.2015.12.016.
To observe whether American Indian and Alaskan Native (AI/AN) patients at the Yakama Indian Health Service seen at the pharmacist-managed asthma clinic improved asthma outcomes.
Retrospective chart review, single group, preintervention and postintervention.
Pharmacist-managed asthma clinic at an Indian Health Service ambulatory care clinic.
Sixty-one AI/AN patients who were seen at least once in the asthma clinic from 2010 to 2014.
Pharmacist-provided asthma education and medication management.
Asthma-related hospitalizations and emergency department or urgent care (ED) visits.
The total number of asthma-related hospitalizations and ED visits between the 12-month periods preceding and following the initial asthma clinic visit were 11 versus 2 hospitalizations (P = 0.02) and 43 versus 25 ED visits (P = 0.02), respectively. Over the same period, asthma-related oral corticosteroid use showed a nonsignificant decrease in the number of prescriptions filled (n = 59, P = 0.08). In contrast, inhaled corticosteroid prescription fills significantly increased (n = 42, P = 0.01).
A reduction of asthma-related hospitalizations and ED visits were observed during the course of the intervention. Increased access to formal asthma education and appropriate asthma care benefit the Yakama AI/AN people. A controlled trial is needed to confirm that the intervention causes the intended effect.
观察在药师管理的哮喘诊所就诊的雅卡马印第安卫生服务机构的美国印第安人和阿拉斯加原住民(AI/AN)患者的哮喘治疗效果是否得到改善。
回顾性病历审查,单组,干预前和干预后。
印第安卫生服务门诊护理诊所的药师管理的哮喘诊所。
2010年至2014年期间在哮喘诊所至少就诊一次的61名AI/AN患者。
药师提供哮喘教育和药物管理。
与哮喘相关的住院治疗以及急诊或紧急护理(ED)就诊情况。
首次哮喘诊所就诊前后12个月期间,与哮喘相关的住院治疗总数和ED就诊次数分别为11次与2次住院(P = 0.02)以及43次与25次ED就诊(P = 0.02)。在同一时期,与哮喘相关的口服皮质类固醇使用的处方填充数量有非显著性下降(n = 59,P = 0.08)。相比之下,吸入皮质类固醇处方填充显著增加(n = 42,P = 0.01)。
在干预过程中观察到与哮喘相关的住院治疗和ED就诊次数减少。增加获得正规哮喘教育和适当哮喘护理的机会对雅卡马AI/AN人群有益。需要进行对照试验来确认该干预措施是否产生预期效果。